Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Gilead Sciences (NQ: GILD ) 83.99 +0.05 (+0.06%) Streaming Delayed Price Updated: 4:00 PM EDT, Sep 23, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 6,474,428 Open 84.25 Bid (Size) 83.75 (5) Ask (Size) 83.92 (1) Prev. Close 83.94 Today's Range 83.48 - 84.46 52wk Range 62.07 - 87.86 Shares Outstanding 1,253,809,440 Dividend Yield 3.57% Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News News Is Noise Today 17:27 EDT Via Talk Markets Gilead Sciences Recalls One Lot Of Its COVID-19 Treatment Due To Presence Of Glass Particles Today 14:12 EDT Gilead Sciences has recalled one lot of its COVID-19 treatment, Veklury (remdesivir), due to glass particles found in vials. Gilead is notifying distributors to cease use and return the remaining... Via Benzinga Topics Product Recall Exposures COVID-19 Legal Product Safety Performance YTD +0.90% +0.90% 1 Month +9.13% +9.13% 3 Month +18.75% +18.75% 6 Month +15.72% +15.72% 1 Year +12.24% +12.24% More News Read More AstraZeneca Dips On Surprise Miss For Gilead-Rivaling Cancer Drug Today 9:38 EDT Via Investor's Business Daily 3 Dirt Cheap Stocks to Buy Right Now September 21, 2024 Via The Motley Fool Gilead Sciences Unusual Options Activity For September 20 September 20, 2024 Via Benzinga Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 3% Dividend Yields September 20, 2024 Via Benzinga $100 Invested In This Stock 20 Years Ago Would Be Worth $900 Today September 13, 2024 Via Benzinga What the Options Market Tells Us About Gilead Sciences September 12, 2024 Via Benzinga Peering Into Gilead Sciences's Recent Short Interest September 06, 2024 Via Benzinga Got $200? 2 Healthcare Stocks to Buy and Hold Forever September 14, 2024 Via The Motley Fool Time To Invest And Or Trade In Bio-Tech Stocks? September 13, 2024 Via Talk Markets Topics ETFs Why Gilead Sciences Stock Thrashed the Market Today September 12, 2024 Via The Motley Fool Gilead Unveils 'Remarkable Outcomes' From Late-Stage Lenacapavir Study Showing Promise In Preventing HIV Infections September 12, 2024 Via Benzinga Gilead Sciences Pops On A New $4 Billion Opportunity In HIV Prevention September 12, 2024 Via Investor's Business Daily Topics Intellectual Property Exposures Intellectual Property Unveiling 10 Analyst Insights On Gilead Sciences September 04, 2024 Via Benzinga Gilead Sciences Options Trading: A Deep Dive into Market Sentiment September 03, 2024 Via Benzinga Decoding Gilead Sciences's Options Activity: What's the Big Picture? August 27, 2024 Via Benzinga Gilead’s Twice-Yearly Lenacapavir for HIV Prevention Reduced HIV Infections by 96% and Demonstrated Superiority to Daily Truvada® in Second Pivotal Phase 3 Trial September 12, 2024 From Gilead Sciences, Inc. Via Business Wire Biotech Breakout: Stocks for Your Watchlist September 12, 2024 Via MarketBeat Topics ETFs Gilead and Genesis Therapeutics Announce Strategic Collaboration to Discover and Develop Novel Therapies September 10, 2024 From Gilead Sciences, Inc. Via Business Wire Four Stocks To Watch This Week - Monday, Sept 9 September 09, 2024 Via Talk Markets Gilead to Present New Trodelvy® Data at the IASLC 2024 World Conference on Lung Cancer September 05, 2024 From Gilead Sciences, Inc. Via Business Wire Merck's Death Cross Vs. Gilead's Golden Cross: Pharma Giants Diverge On Wall Street September 03, 2024 Via Benzinga Biotech And Life Science Sector Update Summer Of 2024 August 29, 2024 Via Talk Markets Galapagos Surges On An FDA Win For Its Rival To Gilead, Novartis; But There Are Some Caveats August 26, 2024 Via Investor's Business Daily Exposures Product Safety Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.